Dexmedetomidine Nasal Spray for the Treatment of Panic Attacks in Adults

NANot yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 30, 2027

Study Completion Date

August 30, 2028

Conditions
Dexmedetomidine
Interventions
DRUG

Dexmedetomidine

30μl

DRUG

Placebo

30μl

All Listed Sponsors
collaborator

Shanghai 10th People's Hospital

OTHER

lead

Yuan Shen

OTHER

NCT07162649 - Dexmedetomidine Nasal Spray for the Treatment of Panic Attacks in Adults | Biotech Hunter | Biotech Hunter